Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 402 - (OTC: $SKDI)
(OTC: $CURR), (OTC: $PSYC)
(OTCQX: $MRMD)
Delta, Kelowna, BC, April 21, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at http://www.investorideas.com/news/2020/cannabis-potcasts/04211SKDI-CURR-PSYC-MRMD.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast will be looking at a few public and private company announcements.
Sun
Kissed Industries Inc. (OTC:SKDI), an
emerging leader in the CBD Food and Beverage marketplace, announced that
its recent acquisition, Products Group Inc, DBA/ Hakuna Supply, has completed
expansion and installation of its new Clean Room facility, which includes a
newly installed industrial mixer, a Nespresso Capsule filling machine, and a
Bagged Coffee filling machine.
The new Clean Room
facility has sharply increased the Company's revenues and productive output:
●
Nespresso Capsule production increased from
2,000/day to 10,000/day
●
Bagged Coffee filling machine driving 500%
increase in per day bagged coffee production
●
New capability to produce single serve
instant coffee pouches
●
Cost of goods sold expected to drop
approximately 30% on a per unit basis
"The results
of our hard-working team have resulted in significantly increased output across
all our product lines and decreased order-to-shipment time frames,"
commented Hakuna CEO, Ilan Freeman. "In addition, we have seen demand
increase over the past couple of months ahead of our expanded marketing
efforts."
The newly expanded
and enhanced Clean Room went into full use at the beginning of April. Hakuna
online sales have increased 30% since the COVID-19 'lock-downs'. The expanded
facilities and new equipment, along with increased marketing investments, have
Hakuna projecting increased revenues across all online product lines on a
month-over-month and year-over-year basis.
Hakuna, a wholly
owned subsidiary, is an award-winning CBD-products company, currently nominated
for "Best Hemp-Derived CBD Product" by the California Cannabis Awards
after winning the DOPE Magazine Best New Product award for Southern California
in the non-cannabis/non-tech category in 2017. Hakuna was also just awarded
"Runner Up" at the Los Angeles Coffee & Donut Festival People's
Choice Coffee Awards for 2019. Hakuna generates significant revenues with a
substantial distribution footprint, including over 110 established retail
distribution partners across over 20 states in the domestic US market.
CURE Pharmaceutical (OTC:
CURR), an innovative drug delivery and development company,
today
announced the issuance of two U.S. Patents: No. 10,639,339 and
10,624,940. These patents represent an expansion of CURE’s existing “product by
process” patents for obtaining multiple unique cannabis concentrates using
super critical fluid extraction (SCFE). These include cannabinoid concentrates
enriched in cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol
(CBG), a non-psychoactive cannabinoid which has shown promising therapeutic
activity in animal studies in areas such as inflammatory bowel disease, cancer
and infectious diseases.
“Adding
CBG to our SCFE patent portfolio aligns with the latest research and early
clinical evidence supporting its therapeutic benefit,” said Rob Davidson, CEO
of CURE Pharmaceutical. “We continue to expand this portfolio to the latest
commercial applications for SCFE, providing our patent licensees and their
customers expanded IP rights.”
CURE
is granting equipment manufacturers, cannabis processing companies and
cannabinoid drug developers licenses to its portfolio of issued and pending
process and composition patents for isolating cannabinoids using an advanced
SCFE technology utilizing carbon dioxide as the solvent. While the patents
cover the incorporation of cannabis extracts into multiple dosage forms, CURE
has retained all rights to applying these methods in oral thin films.
The
two patents cover the extraction and purification of cannabis plant material,
as well as subsequent processing of cannabis extracts for drug formulation.
This extraction and fractioning of bioactive cannabinoid molecules allows for
the integration of these molecules into dosage forms.
Global Trac
Solutions, Inc. (OTC:
PSYC) announced that
they have engaged with a variety of key industry experts in an effort to plan
and prepare for the Company’s intended initial launch set for May 2020. Such
efforts have included identifying and establishing strategic partnerships with
various individuals and companies whom PSYC will look to collaborate with over
the next several weeks and months. The Company will be working on collaborations
in the areas of media, website and brand strategy as it positions itself for
what it anticipates to be a very effective launch into the emerging business
sector of psychedelic medicine.
“In
recent weeks we have witnessed our world and our daily lives change
significantly as a result of the ongoing COVID-19 pandemic. We have also seen a
steady increase in studies and overall focus surrounding a variety of
alternative medicines and treatments, including those associated with
psychedelics based on the possible benefits for treating anxiety, depression,
PTSD, and more. Most recently Rolling Stone Magazine published an interesting
article surrounding Swiss chemist Albert Hoffmann’s psychedelic discovery, and
in it they state, ‘More recently, Silicon Valley billionaires have been
examining the profitability of the industry, neuro-pharmaceutical corporations
are developing commercial psychedelic compounds, and the Wall Street Journal is covering psychedelic startups.’ We were
fortunate to watch the cannabis industry grow into a sustainable marketplace
for both medicinal and recreational use. Part of that journey surrounded
research and development including working alongside industry experts to gain
the knowledge and understanding needed to service that industry. We will be
embarking on the same path for psychedelic medicine by engaging with industry
experts, which will likely expand to a new advisory board and a more defined
approach, which will result in a unique plan to engage this market,” said Vanessa
Luna, CEO of PSYC.
PSYC
is at the forefront of psychedelic medicine, we will work with several
ancillary businesses to provide a network of resources for our current
subscribers, while expanding that network to those pioneers advocating for
change and legislation within this arena.
MariMed Inc. (OTCQX:
MRMD) announced
today that Betty's Eddies™, its proprietary, in-house
award-winning national cannabis brand, will now be available for retail
purchase in Nevada. The expansion is part of MariMed’s plan to increase the
licensing and distribution of its proprietary Brands and Products into
high-growth legal state markets.
Betty’s
Eddies has been one of the top performing cannabis brands in multiple states
across the country, earning the LeafLink award for Best Selling Medical Product
in 2019. Betty's Eddies are gluten-free,
vegan fruit chews made from organically grown fruits and vegetables. Containing
full spectrum cannabis oil, Betty’s Eddies are produced in a wide variety of
dosages and flavors, also offering limited edition varieties by market. Betty’s
Bedtime variety has proven to be a top seller in all markets, helping our
customers achieve much needed rest and sleep.
In
Nevada, MariMed has partnered with Solace Holdings at their state-of-the-art
licensed production and manufacturing facility in Las Vegas. A variety of Betty’s Eddies are now being
sold in Nevada, and can be found at Nuwu Dispensary in Elko, Nevada, with
several more retail locations to be added this month.
Ryan
Crandall, Chief Product Officer and SVP of Sales at MariMed, Inc., commented,
"With a successful launch in the Massachusetts market and continued growth
in Maryland and Rhode Island, Betty's Eddies has achieved substantial sales
growth through the last quarter of 2019 into the first quarter of 2020. The
Betty’s brand is one of the most popular cannabis brands in the United States
today, with innovative new varieties appealing to a wide range of consumer
preferences. As we continue to grow into new markets, we have the opportunity to
serve a broader consumer profile and therefore to evolve our product offerings
in line with the market demand.”
According
to BDS Analytics, Nevada surpassed retail sales expectations in its first year
of adult-use sales, and sales are expected to surpass $1.2 billion by 2022.
With over 45 million visitors a year from all over the world, Nevada is a key
market to building an internationally recognized cannabis brand.
Bob
Fireman, CEO of MariMed, Inc., commented, “As the cannabis marketplace continues
to grow and cannabis consumers explore new and health-focused consumption
options, we believe demand for our brands in Nevada and across our other
markets will grow in lock step. MariMed is dedicated to producing the safest,
highest quality products and we are excited to introduce them to Nevada
adult-use consumers.”
CannaTrac®
Technology, Inc., the leading cashless payment solution for the
cannabis and hemp industries, announced
today that the Company is accepting applications for
retailers looking to adopt the CannaCard® cashless payment system in Illinois,
California, Florida and Ohio.
“We
are thrilled to be accepting applications from retailers and dispensaries
looking to adopt the CannaCard cashless payment platform in California,
Illinois, Florida and Ohio,” said CannaTrac Vice Chairman and CEO Thomas Gavin
IV. “As we continue bringing more retailers on to the CannaCard system, we look
forward to doing our part to increase health and safety standards during these
trying times for both consumers and retailers.”
By
offering CannaCard®, retailers are improving consumer experience through
convenience, increasing safety and providing a healthier environment for
employees, consumers and the community through contactless payments. Retailers
interested in adopting the CannaCard® can apply at https://cannatrac.com/apply/.
CannaCard® applications serve a dual purpose by allowing cannabis businesses to
apply for both acceptance into the cashless payment software system and a
hard-to-come-by bank account with one form.
In
the coming months, CannaTrac expects to launch the CannaCard® in several
additional high demand markets across the U.S.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
No comments:
Post a Comment